Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $121.9600 (-0.49%) ($121.0200 - $123.3600) on Thu. May. 26, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 55 | Latest Price | $121.9600(-0.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.035% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | 0 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $120.51(1.2%) | 10 Day Moving Average | $119.65(1.93%) | 20 Day Moving Average | $119.55(2.02%) | To recent high | -6.5% | To recent low | 32.2% | Market Cap | $1.96b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |